I like:
- Increase of 121% on the March quarter 2019.
- Financial year-end Cash Receipts to June 2019 of $32,221,000 wereup 36% compared to the prior financial year (to June 2018).- This indicates that more EPP patients in Europe arereceiving treatment with SCENESSE® and we look forward to the time the same treatment access can be provided toAmerican EPP patients who have no current alternatives.”
- Net Cash from Operations was positive by $8,618,000 in the June quarter 2019. Net Cash from Operations for thetwelve months to 30 June 2019 was a positive $18,382,000 compared to a positive $11,693,000 in the same twelvemonth period to 30 June 2018.
- Increasing cash balance - Cash Balance as at 30 June2019 increased to $54,269,000, compared to $44,975,000 as at 31 March 2019 and $36,198,000 as at 30 June 2018.
Very positive outlook and building blocks foundation.
Well done!
Ann: Appendix 4C - quarterly, page-4
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.80 |
Change
0.100(0.68%) |
Mkt cap ! $741.5M | |||
| Open | High | Low | Value | Volume |
| $14.60 | $15.00 | $14.31 | $1.171M | 78.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 568 | $14.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.85 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$14.78 |
Change
0.100 ( 0.48 %) |
||||
| Open | High | Low | Volume | ||
| $14.81 | $15.00 | $14.54 | 5844 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| CUV (ASX) Chart |